AU2022213010A1 - Methods of treating al amyloidosis - Google Patents
Methods of treating al amyloidosis Download PDFInfo
- Publication number
- AU2022213010A1 AU2022213010A1 AU2022213010A AU2022213010A AU2022213010A1 AU 2022213010 A1 AU2022213010 A1 AU 2022213010A1 AU 2022213010 A AU2022213010 A AU 2022213010A AU 2022213010 A AU2022213010 A AU 2022213010A AU 2022213010 A1 AU2022213010 A1 AU 2022213010A1
- Authority
- AU
- Australia
- Prior art keywords
- patient
- treatment
- meters
- months
- accession number
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Chemical Treatment Of Metals (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163143728P | 2021-01-29 | 2021-01-29 | |
| US63/143,728 | 2021-01-29 | ||
| PCT/IB2022/050785 WO2022162625A1 (en) | 2021-01-29 | 2022-01-29 | Methods of treating al amyloidosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2022213010A1 true AU2022213010A1 (en) | 2023-08-17 |
| AU2022213010A9 AU2022213010A9 (en) | 2024-09-26 |
Family
ID=80222587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2022213010A Abandoned AU2022213010A1 (en) | 2021-01-29 | 2022-01-29 | Methods of treating al amyloidosis |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20250084153A1 (https=) |
| EP (1) | EP4284829A1 (https=) |
| JP (1) | JP2024505923A (https=) |
| KR (1) | KR20230136643A (https=) |
| CN (1) | CN117098775A (https=) |
| AU (1) | AU2022213010A1 (https=) |
| CA (1) | CA3206326A1 (https=) |
| CL (1) | CL2023002236A1 (https=) |
| IL (1) | IL304755A (https=) |
| JO (1) | JOP20230172A1 (https=) |
| MX (1) | MX2023008835A (https=) |
| TW (1) | TW202332465A (https=) |
| WO (1) | WO2022162625A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH12021552135A1 (en) | 2019-03-05 | 2022-08-31 | Prothena Biosciences Ltd | Methods of treating al amyloidosis |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018005967A1 (en) * | 2016-06-30 | 2018-01-04 | Prothena Therapeutics Limited | Compositions for treating amyloidosis |
| US11382974B2 (en) * | 2017-08-01 | 2022-07-12 | The Trustees Of Columbia University In The City Of New York | Methods and compositions for treatment of amyloid deposition diseases |
| PH12021552135A1 (en) * | 2019-03-05 | 2022-08-31 | Prothena Biosciences Ltd | Methods of treating al amyloidosis |
-
2022
- 2022-01-28 TW TW111104161A patent/TW202332465A/zh unknown
- 2022-01-29 US US18/273,854 patent/US20250084153A1/en active Pending
- 2022-01-29 CN CN202280024675.2A patent/CN117098775A/zh active Pending
- 2022-01-29 KR KR1020237029277A patent/KR20230136643A/ko active Pending
- 2022-01-29 WO PCT/IB2022/050785 patent/WO2022162625A1/en not_active Ceased
- 2022-01-29 JP JP2023546007A patent/JP2024505923A/ja active Pending
- 2022-01-29 CA CA3206326A patent/CA3206326A1/en active Pending
- 2022-01-29 AU AU2022213010A patent/AU2022213010A1/en not_active Abandoned
- 2022-01-29 MX MX2023008835A patent/MX2023008835A/es unknown
- 2022-01-29 EP EP22703077.2A patent/EP4284829A1/en active Pending
-
2023
- 2023-07-25 IL IL304755A patent/IL304755A/en unknown
- 2023-07-27 JO JOJO/P/2023/0172A patent/JOP20230172A1/ar unknown
- 2023-07-28 CL CL2023002236A patent/CL2023002236A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20250084153A1 (en) | 2025-03-13 |
| EP4284829A1 (en) | 2023-12-06 |
| JOP20230172A1 (ar) | 2023-07-27 |
| KR20230136643A (ko) | 2023-09-26 |
| IL304755A (en) | 2023-09-01 |
| CL2023002236A1 (es) | 2024-02-09 |
| CN117098775A (zh) | 2023-11-21 |
| WO2022162625A1 (en) | 2022-08-04 |
| AU2022213010A9 (en) | 2024-09-26 |
| TW202332465A (zh) | 2023-08-16 |
| CA3206326A1 (en) | 2022-08-04 |
| JP2024505923A (ja) | 2024-02-08 |
| MX2023008835A (es) | 2023-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12240894B2 (en) | Methods of treating AL amyloidosis | |
| US20210079078A1 (en) | Compositions for Treating Amyloidosis | |
| WO2022109302A9 (en) | Anti-galectin-9 antibodies and therapeutic uses thereof | |
| US20250084153A1 (en) | Methods of treating al amyloidosis | |
| US20250345418A1 (en) | Methods of treating al amyloidosis | |
| HK40066935B (en) | An antibody for use in methods of treating al amyloidosis | |
| HK40066935A (en) | An antibody for use in methods of treating al amyloidosis | |
| WO2025170969A1 (en) | Methods of treating al amyloidosis | |
| EA048260B1 (ru) | Способы лечения al-амилоидоза | |
| HK40008815B (en) | Compositions for treating amyloidosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| SREP | Specification republished | ||
| MK1 | Application lapsed section 142(2)(a) - no request for examination in relevant period |